RU2601742C2 - Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций - Google Patents

Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций Download PDF

Info

Publication number
RU2601742C2
RU2601742C2 RU2013130256/04A RU2013130256A RU2601742C2 RU 2601742 C2 RU2601742 C2 RU 2601742C2 RU 2013130256/04 A RU2013130256/04 A RU 2013130256/04A RU 2013130256 A RU2013130256 A RU 2013130256A RU 2601742 C2 RU2601742 C2 RU 2601742C2
Authority
RU
Russia
Prior art keywords
sar
methyl
alkyl
meleu
hydroxy
Prior art date
Application number
RU2013130256/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2013130256A (ru
Inventor
Чжуан СУ
Чжэнюй ЛОНГ
Чжэньнянь ХУАН
Суйчжоу ЯН
Original Assignee
Эс энд Ти ГЛОБАЛ ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эс энд Ти ГЛОБАЛ ИНК. filed Critical Эс энд Ти ГЛОБАЛ ИНК.
Publication of RU2013130256A publication Critical patent/RU2013130256A/ru
Application granted granted Critical
Publication of RU2601742C2 publication Critical patent/RU2601742C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2013130256/04A 2010-12-03 2011-12-05 Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций RU2601742C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41932610P 2010-12-03 2010-12-03
US61/419,326 2010-12-03
PCT/US2011/063295 WO2012075494A1 (en) 2010-12-03 2011-12-05 Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Publications (2)

Publication Number Publication Date
RU2013130256A RU2013130256A (ru) 2015-01-10
RU2601742C2 true RU2601742C2 (ru) 2016-11-10

Family

ID=46172312

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013130256/04A RU2601742C2 (ru) 2010-12-03 2011-12-05 Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций

Country Status (13)

Country Link
EP (1) EP2646043B1 (enExample)
JP (1) JP6093307B2 (enExample)
CN (1) CN103249424B (enExample)
AU (1) AU2011336266B2 (enExample)
BR (1) BR112013015771A2 (enExample)
CA (1) CA2819608C (enExample)
DK (1) DK2646043T3 (enExample)
ES (1) ES2625502T3 (enExample)
MX (1) MX350746B (enExample)
PT (1) PT2646043T (enExample)
RU (1) RU2601742C2 (enExample)
WO (1) WO2012075494A1 (enExample)
ZA (1) ZA201303610B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012009715A2 (en) 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
WO2012021796A2 (en) 2010-08-12 2012-02-16 S&T Global, Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
RU2013119869A (ru) 2010-10-12 2014-11-20 Аллерган, Инк. Аналоги циклоспорина
US9175042B2 (en) * 2010-10-12 2015-11-03 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
EP2855508B1 (en) 2012-06-01 2018-02-14 Allergan, Inc. Cyclosporin a analogs
WO2014049540A2 (en) * 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
AU2014232764A1 (en) * 2013-03-15 2015-10-08 Zhengyu Long Novel cyclosporin derivatives and uses thereof
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
CN118324867A (zh) * 2016-05-17 2024-07-12 美国科技环球有限公司 新型环孢菌素衍生物及其用途
WO2020152037A1 (en) 2019-01-24 2020-07-30 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3686252A1 (en) 2019-01-24 2020-07-29 Agfa-Gevaert Nv Radiation curable inkjet ink for manufacturing printed circuit boards
US12226446B2 (en) 2019-10-11 2025-02-18 Waterstone Pharmaceuticals(Wuhan) Co., Ltd. WS-635 uses thereof in medicine
CN113694177B (zh) 2020-04-15 2022-06-17 睿诺医疗科技(上海)有限公司 器官损伤的预防和治疗
US20220296676A1 (en) * 2020-06-04 2022-09-22 Waterstone Pharmaceuticals(Wuhan) Co., Ltd. Treatment or prevention of coronaviridae infection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703033A (en) * 1985-03-11 1987-10-27 Sandoz Ltd. Novel cyclosporins
US7718767B2 (en) * 2004-10-01 2010-05-18 Scynexis, Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
RU2011127080A (ru) * 2009-01-07 2013-02-20 Сайнексис, Инк. Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL324531A1 (en) * 1995-07-17 1998-06-08 Chem Ag C Derivatives of cyclosporin effective against hiv virus
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
JP5139065B2 (ja) * 2004-10-01 2013-02-06 スシネキス インク C型肝炎感染の治療及び予防のための3−エーテル及び3−チオエーテル置換シクロスポリン誘導体
ZA200703157B (en) * 2004-10-01 2008-08-27 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
SG173180A1 (en) * 2009-01-30 2011-09-29 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
WO2012021796A2 (en) * 2010-08-12 2012-02-16 S&T Global, Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703033A (en) * 1985-03-11 1987-10-27 Sandoz Ltd. Novel cyclosporins
US7718767B2 (en) * 2004-10-01 2010-05-18 Scynexis, Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
RU2011127080A (ru) * 2009-01-07 2013-02-20 Сайнексис, Инк. Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич

Also Published As

Publication number Publication date
EP2646043B1 (en) 2017-02-15
DK2646043T3 (da) 2017-05-22
EP2646043A4 (en) 2014-05-28
CA2819608A1 (en) 2012-06-07
AU2011336266A1 (en) 2013-06-27
MX2013006254A (es) 2013-10-30
RU2013130256A (ru) 2015-01-10
ZA201303610B (en) 2014-07-30
CA2819608C (en) 2020-03-31
CN103249424A (zh) 2013-08-14
ES2625502T3 (es) 2017-07-19
JP2014500265A (ja) 2014-01-09
EP2646043A1 (en) 2013-10-09
JP6093307B2 (ja) 2017-03-08
MX350746B (es) 2017-09-14
PT2646043T (pt) 2017-05-09
CN103249424B (zh) 2016-08-10
WO2012075494A1 (en) 2012-06-07
AU2011336266B2 (en) 2017-04-06
BR112013015771A2 (pt) 2018-11-06

Similar Documents

Publication Publication Date Title
AU2011336266B2 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9573978B2 (en) Cyclosporin derivatives for the treatment and prevention of a viral infection
JP7637421B2 (ja) 新規シクロスポリン誘導体及びその使用
US9217015B2 (en) Cyclosporin derivatives for the treatment and prevention of a viral infection
US10647747B2 (en) Cyclosporin derivatives and uses thereof
US20160039879A1 (en) Novel cyclosporin derivatives and uses thereof
HK1201181A1 (en) Novel cyclosporin derivatives for the treatment and prevention of viral infections
HK1188134B (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
HK1188134A (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
HK40005642A (en) Novel cyclosporin derivatives and uses thereof

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20170222